Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prevalence Study to Evaluate the Infectious and Immunological Status of COVID-19 in Asymptomatic Subjects Attending ART Centres After the Pandemic Lockdown in the USA

NCT04466644 is registered in ClinicalTrials.gov with Igenomix as lead sponsor.

NCT NCT04466644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prevalence Study to Evaluate the Infectious and Immunological Status of COVID-19 in Asymptomatic Subjects Attending ART Centres After the Pandemic Lockdown in the USA
Lead sponsor
Igenomix
Phase
Observational
Overall status
Completed
Start date
June 8, 2020
Completion date
August 25, 2020
Enrollment
340 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19